Empirical Finance’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $257K | Buy |
9,300
+85
| +0.9% | +$2.35K | 0.01% | 486 |
|
|
2025
Q1 | $261K | Buy |
9,215
+624
| +7% | +$17.7K | 0.02% | 477 |
|
|
2024
Q4 | $357K | Sell |
8,591
-22
| -0.3% | -$915 | 0.02% | 447 |
|
|
2024
Q3 | $576K | Buy |
8,613
+334
| +4% | +$22.3K | 0.03% | 394 |
|
|
2024
Q2 | $983K | Sell |
8,279
-696
| -8% | -$82.7K | 0.06% | 269 |
|
|
2024
Q1 | $956K | Buy |
8,975
+399
| +5% | +$42.5K | 0.06% | 286 |
|
|
2023
Q4 | $853K | Buy |
8,576
+190
| +2% | +$18.9K | 0.06% | 287 |
|
|
2023
Q3 | $866K | Buy |
8,386
+1,157
| +16% | +$120K | 0.06% | 264 |
|
|
2023
Q2 | $878K | Buy |
7,229
+1,215
| +20% | +$148K | 0.07% | 261 |
|
|
2023
Q1 | $924K | Buy |
6,014
+700
| +13% | +$108K | 0.09% | 226 |
|
|
2022
Q4 | $955K | Buy |
5,314
+633
| +14% | +$114K | 0.1% | 209 |
|
|
2022
Q3 | $554K | Buy |
4,681
+1,382
| +42% | +$164K | 0.07% | 276 |
|
|
2022
Q2 | $471K | Buy |
3,299
+358
| +12% | +$51.1K | 0.06% | 287 |
|
|
2022
Q1 | $507K | Buy |
2,941
+749
| +34% | +$129K | 0.06% | 305 |
|
|
2021
Q4 | $557K | Buy |
+2,192
| New | +$557K | 0.07% | 274 |
|